Cas:238088-31-8 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propanenitrile manufacturer & supplier

We serve Chemical Name:3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propanenitrile CAS:238088-31-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propanenitrile

Chemical Name:3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propanenitrile
CAS.NO:238088-31-8
Synonyms:1,3,2-Dioxaborolane-2-propanenitrile,4,4,5,5-tetramethyl;2-Cyanoethyl-1-boronic acid pinacol ester
Molecular Formula:C9H16BNO2
Molecular Weight:181.04000
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:42.25000
Exact Mass:181.12700
LogP:1.99228

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,3,2-Dioxaborolane-2-propanenitrile,4,4,5,5-tetramethyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Cyanoethyl-1-boronic acid pinacol ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3,2-Dioxaborolane-2-propanenitrile,4,4,5,5-tetramethyl Use and application,2-Cyanoethyl-1-boronic acid pinacol ester technical grade,usp/ep/jp grade.


Related News: The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. 5,6-dichloro-3H-benzotriazole-1-oxide manufacturers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. N-[2-(N,N-dimethylamino)ethyl]-4-[methyl(4-nitrobenzyl)amino]phenylacetamide suppliers The Company has run a comprehensive range of specialized in vitro and in vivo tests on its patent-pending novel compounds to select the optimal psychedelic drug candidate for progressing towards human clinical trials. (E)-3-(1-Trityl-aziridin-2-yl)-acrylic acid methyl ester vendor & factory.